Advertisement
Screener

HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Pre-Tax Margin

Harmony Biosciences Holdings, Inc. Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Harmony Biosciences Holdings, Inc. pre-tax margin for the quarter ending 2026-06-30 was 35.70%, a 44.18% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for the quarter ending 2026-03-31 was 18.43%, a 40.47% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for the quarter ending 2025-12-31 was 16.72%, a 40.07% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for the quarter ending 2025-09-30 was 28.18%, a 15.66% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for fiscal 2025 was 24.76%, a 7.72% decline from fiscal 2024.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for fiscal 2024 was 26.84%, a 9.92% decline from fiscal 2023.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for fiscal 2023 was 29.79%, a 24.61% increase from fiscal 2022.
  • Harmony Biosciences Holdings, Inc. pre-tax margin for fiscal 2022 was 23.91%, a 95.11% increase from fiscal 2021.
Available history
2019-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2026-06-3035.70%$93.27M$261.28M
2026-03-3118.43%$39.69M$215.39M
2025-12-3116.72%$40.76M$243.78M
2025-09-3028.18%$67.49M$239.46M
2025-06-3024.76%$49.64M$200.49M
2025-03-3130.95%$57.18M$184.73M
2024-12-3127.90%$56.16M$201.27M
2024-09-3033.42%$62.17M$186.04M
2024-06-3012.55%$21.69M$172.81M
2024-03-3133.49%$51.79M$154.62M
2023-12-3123.57%$39.69M$168.41M
2023-09-3032.34%$51.83M$160.27M
2023-06-3032.85%$44.1M$134.22M
2023-03-3131.71%$37.78M$119.13M
2022-12-3134.37%$44.1M$128.31M
2022-09-306.80%$7.97M$117.21M
2022-06-3027.31%$29.23M$107.03M
2022-03-3127.41%$23.39M$85.31M
2021-12-3126.83%$24.48M$91.21M
2021-09-30-13.03%-$10.52M$80.73M
2021-06-3021.79%$16.09M$73.82M
2021-03-3112.38%$7.39M$59.67M
2020-12-31-0.37%-$208,000.00$56.29M
2020-09-304.19%$1.91M$45.61M
2020-06-30-0.07%-$27,000.00$38.01M
2020-03-31-194.66%-$38.62M$19.84M

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-3124.76%$215.06M$868.45M
2024-12-3126.84%$191.8M$714.73M
2023-12-3129.79%$173.4M$582.02M
2022-12-3123.91%$104.69M$437.86M
2021-12-3112.25%$37.43M$305.44M
2020-12-31-23.13%-$36.94M$159.74M
2019-12-31-2535.06%-$151.98M$6M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
uniQure N.V. (QURE)$2.416B-4.93
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34